1	Concomitant	concomitant	_	_	_	_	_	_	_
2	downregulation	downregulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	IgH	IgH	_	_	_	_	_	_	_
5	3	3	_	_	_	_	_	_	_
6	’	'	_	_	_	_	_	_	_
7	enhancer	enhancer	_	_	_	_	_	_	_
8	activity	activity	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	c-myc	c-myc	_	_	_	_	_	_	_
11	expression	expression	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	plasmacytoma	plasmacytoma	_	_	_	_	_	_	_
15	x	x	_	_	_	_	_	_	_
16	fibroblast	fibroblast	_	_	_	_	_	_	_
17	environment	environment	_	_	_	_	_	_	_
18	:	:	_	_	_	_	_	_	_
19	implications	implication	_	_	_	_	_	_	_
20	for	for	_	_	_	_	_	_	_
21	dysregulation	dysregulation	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	translocated	translocate	_	_	_	_	_	_	_
24	c-myc	c-myc	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Regulation	regulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	immunoglobulin	immunoglobulin	_	_	_	_	_	_	_
4	heavy	heavy	_	_	_	_	_	_	_
5	chain	chain	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	IgH	IgH	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	gene	gene	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	controlled	control	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	B	B	_	_	_	_	_	_	_
16	cell-specific	cell-specific	_	_	_	_	_	_	_
17	promoter	promoter	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	intronic	intronic	_	_	_	_	_	_	_
20	enhancer	enhancer	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	additional	additional	_	_	_	_	_	_	_
23	B	B	_	_	_	_	_	_	_
24	cell-specific	cell-specific	_	_	_	_	_	_	_
25	enhancer	enhancer	_	_	_	_	_	_	_
26	elements	element	_	_	_	_	_	_	_
27	identified	identify	_	_	_	_	_	_	_
28	recently	recently	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	3	3	_	_	_	_	_	_	_
32	’	'	_	_	_	_	_	_	_
33	end	end	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	the	the	_	_	_	_	_	_	_
36	IgH	IgH	_	_	_	_	_	_	_
37	locus	locus	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	One	one	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	latter	latter	_	_	_	_	_	_	_
5	elements	element	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	IgH	IgH	_	_	_	_	_	_	_
9	3	3	_	_	_	_	_	_	_
10	’	'	_	_	_	_	_	_	_
11	enhancer	enhancer	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	particular	particular	_	_	_	_	_	_	_
16	interest	interest	_	_	_	_	_	_	_
17	:	:	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	1	1	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	it	it	_	_	_	_	_	_	_
22	is	be	_	_	_	_	_	_	_
23	B	B	_	_	_	_	_	_	_
24	cell-specific	cell-specific	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	active	active	_	_	_	_	_	_	_
27	only	only	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	late	late	_	_	_	_	_	_	_
30	B	B	_	_	_	_	_	_	_
31	cell	cell	_	_	_	_	_	_	_
32	development	development	_	_	_	_	_	_	_
33	;	;	_	_	_	_	_	_	_
34	(	(	_	_	_	_	_	_	_
35	2	2	_	_	_	_	_	_	_
36	)	)	_	_	_	_	_	_	_
37	in	in	_	_	_	_	_	_	_
38	rodent	rodent	_	_	_	_	_	_	_
39	plasmacytomas	plasmacytoma	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	some	some	_	_	_	_	_	_	_
43	human	human	_	_	_	_	_	_	_
44	Burkitt	Burkitt	_	_	_	_	_	_	_
45	’s	's	_	_	_	_	_	_	_
46	lymphomas	lymphoma	_	_	_	_	_	_	_
47	it	it	_	_	_	_	_	_	_
48	is	be	_	_	_	_	_	_	_
49	part	part	_	_	_	_	_	_	_
50	of	of	_	_	_	_	_	_	_
51	a	a	_	_	_	_	_	_	_
52	locus	locus	_	_	_	_	_	_	_
53	control	control	_	_	_	_	_	_	_
54	region	region	_	_	_	_	_	_	_
55	(	(	_	_	_	_	_	_	_
56	LCR	LCR	_	_	_	_	_	_	_
57	)	)	_	_	_	_	_	_	_
58	that	that	_	_	_	_	_	_	_
59	is	be	_	_	_	_	_	_	_
60	involved	involve	_	_	_	_	_	_	_
61	in	in	_	_	_	_	_	_	_
62	deregulation	deregulation	_	_	_	_	_	_	_
63	of	of	_	_	_	_	_	_	_
64	the	the	_	_	_	_	_	_	_
65	c-myc	c-myc	_	_	_	_	_	_	_
66	oncogene	oncogene	_	_	_	_	_	_	_
67	as	as	_	_	_	_	_	_	_
68	a	a	_	_	_	_	_	_	_
69	result	result	_	_	_	_	_	_	_
70	of	of	_	_	_	_	_	_	_
71	translocation	translocation	_	_	_	_	_	_	_
72	into	into	_	_	_	_	_	_	_
73	the	the	_	_	_	_	_	_	_
74	IgH	IgH	_	_	_	_	_	_	_
75	locus	locus	_	_	_	_	_	_	_
76	;	;	_	_	_	_	_	_	_
77	and	and	_	_	_	_	_	_	_
78	(	(	_	_	_	_	_	_	_
79	3	3	_	_	_	_	_	_	_
80	)	)	_	_	_	_	_	_	_
81	it	it	_	_	_	_	_	_	_
82	has	have	_	_	_	_	_	_	_
83	been	be	_	_	_	_	_	_	_
84	implicated	implicate	_	_	_	_	_	_	_
85	in	in	_	_	_	_	_	_	_
86	the	the	_	_	_	_	_	_	_
87	mechanisms	mechanism	_	_	_	_	_	_	_
88	that	that	_	_	_	_	_	_	_
89	control	control	_	_	_	_	_	_	_
90	Ig	ig	_	_	_	_	_	_	_
91	gene	gene	_	_	_	_	_	_	_
92	class	class	_	_	_	_	_	_	_
93	switch	switch	_	_	_	_	_	_	_
94	recombination	recombination	_	_	_	_	_	_	_
95	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	used	use	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	somatic	somatic	_	_	_	_	_	_	_
6	cell	cell	_	_	_	_	_	_	_
7	hybridization	hybridization	_	_	_	_	_	_	_
8	approach	approach	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	genetically	genetically	_	_	_	_	_	_	_
11	analyse	analyse	_	_	_	_	_	_	_
12	regulation	regulation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	IgH	IgH	_	_	_	_	_	_	_
19	3	3	_	_	_	_	_	_	_
20	’	'	_	_	_	_	_	_	_
21	enhancer	enhancer	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	When	when	_	_	_	_	_	_	_
2	mouse	mouse	_	_	_	_	_	_	_
3	MPC11	mpc11	_	_	_	_	_	_	_
4	plasmacytoma	plasmacytoma	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	which	which	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	IgH	IgH	_	_	_	_	_	_	_
11	3	3	_	_	_	_	_	_	_
12	’	'	_	_	_	_	_	_	_
13	enhancer	enhancer	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	active	active	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	are	be	_	_	_	_	_	_	_
18	fused	fuse	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	fibroblasts	fibroblast	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	Ig	ig	_	_	_	_	_	_	_
23	expression	expression	_	_	_	_	_	_	_
24	is	be	_	_	_	_	_	_	_
25	extinguished	extinguish	_	_	_	_	_	_	_
26	at	at	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	level	level	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	transcription	transcription	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	MPC11	mpc11	_	_	_	_	_	_	_
8	plasmacytoma	plasmacytoma	_	_	_	_	_	_	_
9	x	x	_	_	_	_	_	_	_
10	fibroblast	fibroblast	_	_	_	_	_	_	_
11	environment	environment	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	IgH	IgH	_	_	_	_	_	_	_
15	3	3	_	_	_	_	_	_	_
16	’	'	_	_	_	_	_	_	_
17	enhancer	enhancer	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	transcriptionally	transcriptionally	_	_	_	_	_	_	_
20	inactive	inactive	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	demonstrate	demonstrate	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	binding	binding	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	several	several	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	cell-specific	cell-specific	_	_	_	_	_	_	_
11	transcription	transcription	_	_	_	_	_	_	_
12	factors	factor	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	essential	essential	_	_	_	_	_	_	_
15	for	for	_	_	_	_	_	_	_
16	IgH	IgH	_	_	_	_	_	_	_
17	3	3	_	_	_	_	_	_	_
18	’	'	_	_	_	_	_	_	_
19	enhancer	enhancer	_	_	_	_	_	_	_
20	activity	activity	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	is	be	_	_	_	_	_	_	_
23	lacking	lack	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	which	which	_	_	_	_	_	_	_
26	may	may	_	_	_	_	_	_	_
27	explain	explain	_	_	_	_	_	_	_
28	3	3	_	_	_	_	_	_	_
29	’	'	_	_	_	_	_	_	_
30	enhancer	enhancer	_	_	_	_	_	_	_
31	inactivity	inactivity	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	although	although	_	_	_	_	_	_	_
34	the	the	_	_	_	_	_	_	_
35	binding	binding	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	repressors	repressor	_	_	_	_	_	_	_
38	cannot	cannot	_	_	_	_	_	_	_
39	be	be	_	_	_	_	_	_	_
40	excluded	exclude	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	Moreover	moreover	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	high	high	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	level	level	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	c-myc	c-myc	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	characteristic	characteristic	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	parental	parental	_	_	_	_	_	_	_
14	MPC11	mpc11	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	carrying	carry	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	t(12;15)	t(12;15)	_	_	_	_	_	_	_
19	translocation	translocation	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	is	be	_	_	_	_	_	_	_
22	down-regulated	down-regulate	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	hybrids	hybrid	_	_	_	_	_	_	_
26	to	to	_	_	_	_	_	_	_
27	that	that	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	unfused	unfused	_	_	_	_	_	_	_
30	fibroblasts	fibroblast	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Therefore	therefore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	inactivation	inactivation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	IgH	IgH	_	_	_	_	_	_	_
7	3	3	_	_	_	_	_	_	_
8	’	'	_	_	_	_	_	_	_
9	enhancer	enhancer	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	multifactorial	multifactorial	_	_	_	_	_	_	_
13	process	process	_	_	_	_	_	_	_
14	affecting	affect	_	_	_	_	_	_	_
15	several	several	_	_	_	_	_	_	_
16	transcription	transcription	_	_	_	_	_	_	_
17	factors	factor	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	control	control	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	cell-specific	cell-specific	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	developmental	developmental	_	_	_	_	_	_	_
24	activity	activity	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	enhancer	enhancer	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

